✦ LIBER ✦

660 Safety Aspects of the Introduction of Everolimus in Cardiac Recipients with Established Allograft Vasculopathy: Results of a Randomized, Multicenter Study

✍ Scribed by J. Segovia; J. Palomo; F. González-Vílchez; J. Delgado; V. Brossa; N. Manito; F. Pérez-Villa; G. Rábago; M. Gómez-Bueno; L. Alonso-Pulpón

Book ID: 116524311
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 93 KB
Volume: 31
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2012.01.674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

206 Effect of Everolimus in Patients wit

206 Effect of Everolimus in Patients with Established Cardiac Allograft Vasculopathy: Results of a Randomized, Multicenter Intravascular Ultrasound Study

✍ J. Segovia; M. Gómez-Bueno; J. Goicolea; J. Elízaga; J. Fernández-Yáñez; J. Palo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 170 KB

52 Reduction of Cardiac Allograft Vascul

52 Reduction of Cardiac Allograft Vasculopathy with Everolimus over Mycophenolate Mofetil: Intravascular Ultrasound Results of a Randomized Multicenter Trial

✍ J. Kobashigawa; D. Pauly; H. Ross; S. Wang; B. Cantin; J. Burton; A. Keogh; H. E 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 186 KB

339 Clinical Effects of Introducing Ever

339 Clinical Effects of Introducing Everolimus in the Immunosuppressive Regimen of Patients with Established Cardiac Allograft Vasculopathy (CAV): Efficacy Analysis of a Randomized, Multicenter Study

✍ J. Segovia; J. Fernández-Yáñez; F.J. González-Vílchez; J. Delgado; S. Mirabet; N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 164 KB

24-month safety results of a randomized,

24-month safety results of a randomized, multicenter, double-blind study of Everolimus vs azathioprine in de novo heart transplant recipients

✍ H Eisen; J Kobashigawa; R.C Starling; N Cretin; J.S Jaffe; J Murphy 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Lower incidence of cytomegalovirus infec

Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study

✍ M. Viganò; T. Dengler; M.F. Mattei; A. Poncelet; J. Vanhaecke; E. Vermes; R. Kle 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

15: Results of a 12-Month, Multicenter,

15: Results of a 12-Month, Multicenter, Randomized Trial of Everolimus with Reduced-Exposure Cyclosporine Versus MMF and Standard-Exposure Cyclosporine in De Novo Cardiac Transplant Recipients

✍ H. Lehmkuhl; U. Livi; J. Arizon; M. Viganò; C. Magelli; P. Boissonnat; G. Gerosa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 112 KB